Brief: Sk Biopharmaceuticals Signs Technology Transfer Agreement Worth $505 Mln With Ono Pharmaceutical Co
Oct 13 (Reuters) -
* SK BIOPHARMACEUTICALS: SIGNS TECHNOLOGY TRANSFER AGREEMENT
WORTH
579 BILLION WON ($504.61 million) WITH ONO PHARMACEUTICAL CO
Source text for Eikon: https://bit.ly/3lFzJVR
Further company coverage: 326030.KS
($1 = 1,147.4300 won)
((Heekyong.Yang@thomsonreuters.com;))
Recent news on SK Biopharmaceuticals Co
See all newsInsilico Medicine hits 3-week high on SK Biopharmaceuticals tie-up
Signs Joint Rd Partnership Agreement With Insilico Medicine
Brief: Insilico Medicine Cayman TopCo Says Co & SK Biopharmaceuticals Enter AI-Powered RD Collab Worth Up To $2.5 Bln
Brief: SK Life Science Announces FDA Acceptance For Review Of New Drug Application For Cenobamate Oral Suspension
Announces Pharmaceutical Supply Contract